Randy Ban - Jan 4, 2022 Form 4 Insider Report for Inspire Medical Systems, Inc. (INSP)

Role
Chief Commercial Officer
Signature
/s/ Richard Buchholz, as Attorney-in-Fact for Randy Ban
Stock symbol
INSP
Transactions as of
Jan 4, 2022
Transactions value $
-$2,470,805
Form type
4
Date filed
1/6/2022, 03:15 PM
Previous filing
Dec 28, 2021
Next filing
Feb 15, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction INSP Common Stock Options Exercise $10.4K +5.04K +1892.86% $2.07* 5.3K Jan 4, 2022 Direct F1
transaction INSP Common Stock Options Exercise $1.64K +1.74K +32.82% $0.94* 7.04K Jan 4, 2022 Direct
transaction INSP Common Stock Sale -$1.63M -6.78K -96.22% $240.00 266 Jan 4, 2022 Direct F2
transaction INSP Common Stock Options Exercise $7.31K +3.53K +1327.82% $2.07* 3.8K Jan 5, 2022 Direct
transaction INSP Common Stock Sale -$864K -3.53K -93% $244.67 266 Jan 5, 2022 Direct F2
holding INSP Common Stock 167 Jan 4, 2022 By son
holding INSP Common Stock 166 Jan 4, 2022 By daughter

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INSP Stock Option (Right to Buy) Options Exercise $0 -5.04K -58.77% $0.00 3.53K Jan 4, 2022 Common Stock 5.04K $2.07 Direct F3
transaction INSP Stock Option (Right to Buy) Options Exercise $0 -1.74K -23.92% $0.00 5.53K Jan 4, 2022 Common Stock 1.74K $0.94 Direct F3
transaction INSP Stock Option (Right to Buy) Options Exercise $0 -3.53K -100% $0.00* 0 Jan 5, 2022 Common Stock 3.53K $2.07 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 18 additional shares acquired under the Inspire Medical Systems, Inc. 2018 Employee Stock Purchase Plan since the Reporting Person's ownership report filed on December 28, 2021.
F2 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan dated November 5, 2021.
F3 The option is fully vested and exercisable.